Brief: Diamedica Therapeutics Provides A Business Update And Announces First Quarter 2023 Financial Results
15/05/2023 22:36
DiaMedica Therapeutics Inc DMAC.O :
* DIAMEDICA THERAPEUTICS PROVIDES A BUSINESS UPDATE AND
ANNOUNCES
FIRST QUARTER 2023 FINANCIAL RESULTS
* DIAMEDICA THERAPEUTICS INC- CASH RUNWAY INTO Q4 2024
* DIAMEDICA THERAPEUTICS INC- PLANS TO FILE COMPLETE
RESPONSE
REQUESTING HOLD LIFT THIS WEEK FOR REMEDY2 PHASE 2/3 TRIAL FOR
ACUTE ISCHEMIC STROKE
* DIAMEDICA THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.20
Source text for Eikon: ID:nBw7PWbn4a
Further company coverage: DMAC.O
Recent news on DiaMedica Therapeutics
See all newsBrief: Diamedica Therapeutics Announces Enrollment Of 200Th Patient In Remedy2 Phase 2/3 Acute Ischemic Stroke Trial
DiaMedica Q2 net loss widen less than expected
DiaMedica Therapeutics Inc expected to post a loss of 20 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Qualcomm, Robinhood
Brief: Diamedica Receives FDA Feedback On Dm199 Preeclampsia Nonclinical Program